Literature DB >> 20514336

Simultaneous multi-vessel subacute stent thromboses in zotarolimus-eluting stents.

Yong-Hyun Kim1, Soon Yong Suh, Seong Hwan Kim, Sang-Yup Lim, Seung-Young Roh, Ji-Bak Kim, Woo Hyuk Song, Jeong Cheon Ahn.   

Abstract

Despite its low incidence, stent thrombosis (ST) is one of the most dreaded complications of percutaneous coronary intervention. Endeavor (Medtronics Europe SA) is a new zotarolimus-eluting stent (ZES) with a favorable safety profile that was reported in early and ongoing trials. However, few lethal stent thromboses related to this new drug eluting stent (DES) have been reported. We experienced a case of simultaneous subacute ZES thromboses, 6 days after stent implantations in the proximal left anterior descending artery and the proximal right coronary artery (RCA).

Entities:  

Keywords:  Drug-eluting stents; Stents; Thrombosis; Zotarolimus

Year:  2010        PMID： 20514336      PMCID： PMC2877790          DOI： 10.4070/kcj.2010.40.5.243

Source DB:  PubMed          Journal:  Korean Circ J        ISSN： 1738-5520            Impact factor:   3.243


  10 in total

1.  Subacute thrombosis following implantation of zotarolimus-eluting stent.

Authors:  Socrates Korovesis; Eleftherios Giazitzoglou; Demosthenes G Katritsis
Journal:  Hellenic J Cardiol       Date:  2006 Sep-Oct

2.  Stent thrombosis in randomized clinical trials of drug-eluting stents.

Authors:  Laura Mauri; Wen-hua Hsieh; Joseph M Massaro; Kalon K L Ho; Ralph D'Agostino; Donald E Cutlip
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

Review 3.  Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.

Authors:  Lisette Okkels Jensen; Michael Maeng; Anne Kaltoft; Per Thayssen; Hans Henrik Tilsted Hansen; Morten Bottcher; Jens Flensted Lassen; Lars Romer Krussel; Klaus Rasmussen; Knud Noerregaard Hansen; Lars Pedersen; Soeren Paaske Johnsen; Henrik Toft Soerensen; Leif Thuesen
Journal:  J Am Coll Cardiol       Date:  2007-06-29       Impact factor: 24.094

4.  Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

Authors:  David E Kandzari; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; Charles O'Shaughnessy; Michael W Ball; Mark Turco; Robert J Applegate; Paul A Gurbel; Mark G Midei; Sejal S Badre; Laura Mauri; Kweli P Thompson; LeRoy A LeNarz; Richard E Kuntz
Journal:  J Am Coll Cardiol       Date:  2006-11-28       Impact factor: 24.094

Review 5.  Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.

Authors:  Jun-ichi Kotani; Masaki Awata; Shinsuke Nanto; Masaaki Uematsu; Fusako Oshima; Hitoshi Minamiguchi; Gary S Mintz; Seiki Nagata
Journal:  J Am Coll Cardiol       Date:  2006-04-04       Impact factor: 24.094

6.  Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

Authors:  Jean Fajadet; William Wijns; Gert-Jan Laarman; Karl-Heinz Kuck; John Ormiston; Thomas Münzel; Jeffrey J Popma; Peter J Fitzgerald; Raoul Bonan; Richard E Kuntz
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

7.  Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents.

Authors:  Seong Hwan Kim; Eung Ju Kim; Soon Yong Suh; Cheol Ung Choi; Jin Won Kim; Seung Woon Rha; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Int J Cardiol       Date:  2006-11-09       Impact factor: 4.164

8.  Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.

Authors:  Feng Zhang; Juying Qian; Junbo Ge
Journal:  J Invasive Cardiol       Date:  2008-08       Impact factor: 2.022

9.  Simultaneous subacute stent thrombosis of two sirolimus-eluting stents in a patient treated by ReoPro, thrombus aspiration and triple anti-platelet agents.

Authors:  Jae-Youn Moon; Jong Won Chung; Ju Han Kim; Young Keun Ahn; Myung Ho Jeong
Journal:  Int J Cardiol       Date:  2007-10-25       Impact factor: 4.164

10.  Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.

Authors:  Shlomi Matetzky; Boris Shenkman; Victor Guetta; Michael Shechter; Roy Beinart; Roy Bienart; Ilan Goldenberg; Ilya Novikov; Hanna Pres; Naphtali Savion; David Varon; Hanoch Hod
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.